Psilera Names Allyson Gage Clinical Development VP Ahead of PSIL-006 Phase 1 Trial

Thursday, August 27, 2026Sobeida DiloneView original
Psilera Names Allyson Gage Clinical Development VP Ahead of PSIL-006 Phase 1 Trial

Psilera has appointed neuroscience drug development veteran Allyson Gage, PhD, as vice president of clinical development, putting her in charge... Read More

The post Psilera Names Allyson Gage Clinical Development VP Ahead of PSIL-006 Phase 1 Trial appeared first on citybiz.